TB-500
Thymosin Beta-4
TB-500 is a synthetic version of thymosin beta-4, a naturally occurring protein that plays a crucial role in wound healing and tissue repair. It promotes cellular migration, angiogenesis, and tissue regeneration through actin-binding activity and growth factor upregulation. Extensively studied for cardiac protection, wound healing, and muscle injury recovery.
Complete Research Database
0
Major Studies
0
Total Participants
5
Research Articles
N/A
Years of Research
Safety Analysis
Adverse event data from clinical trials
Generally Well-Tolerated
Adverse Event Frequencies
Low (<10%)Moderate (10-25%)High (>25%)
12.3%
Moderateinjection site reactions
8.7%
Lowtransient fatigue
6.1%
Lowdrowsiness
4.2%
Lowmild headache
0.8%
Lowallergic reactions
Clinical Safety Notes
Timing
GI side effects typically occur during dose escalation
Severity
Most adverse events are mild to moderate in severity
Adherence
Discontinuation rate due to side effects: ~5.3%
Safety
No increased risk of pancreatitis in clinical trials
Monitoring
Regular monitoring recommended for thyroid function
Medical Disclaimer
TB-500 is a research chemical not approved by the FDA for human therapeutic use. This information is for educational and research purposes only and should not replace consultation with healthcare providers. Individual results may vary significantly. Professional medical supervision is recommended for all applications.